how model-based approaches can improve precision dosing in clinical care
Published 7 years ago • 602 plays • Length 43:04Download video MP4
Download video MP3
Similar videos
-
44:54
how model based personalized drug dosing will revolutionize healthcare
-
40:57
precision dosing using pbpk modeling
-
38:36
getting at the haart of precision dosing: using pbpk models to optimize dosing of an antiviral
-
44:57
using modeling and simulation to optimize dosing of an anti-infective for children
-
7:33
certara: biosimulation paves the way for precision dosing
-
18:14
using pop pk modeling to optimize dosing in patients with organ impairment
-
45:33
using model-based meta-analysis to improve decision-making in drug development
-
55:39
a best practice framework for applying pbpk modeling to pediatric drug development
-
36:57
how to use a reference scaled average bioequivalence approach for narrow therapeutic index drugs
-
47:14
pml school: minimal physiologically-based pharmacokinetic model for monoclonal antibodies (mabs)
-
57:41
mechanistic long-acting injectable model for plga polymer implants
-
21:13
ai for evidence-based covariate adjustment in clinical trials | ai & pharma | félix balazard
-
1:00:21
optimize drug development with public data and predictive models – model-based meta-analysis (mbma)
-
1:05:56
leveraging modeling and simulation for neonatal and infant drug development
-
1:02:16
leveraging dermal pbpk modeling and simulation approaches
-
30:38
clinical track: towards a flexible model-informed precision dosing software solution using...
-
52:55
enhance your drug development capacity with clin pharm study execution & operational support
-
59:49
pbpk modeling approaches to assess risks associated with bioequivalence in drug development
-
11:17
modeling and simulation to support pediatric drug development
-
33:21
using model based meta analysis to inform drug development for auto immune diseases
-
49:40
pbpk modeling and simulation: bridging the “bottom up” and “top-down” approaches
-
59:17
applications of pbpk modelling for regulatory submissions: case studies